{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:23:03Z","timestamp":1793784183009,"version":"4.6.1"},"update-to":[{"DOI":"10.1002\/14651858.cd002025.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000}}],"reference-count":163,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002025.pub5","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T15:56:14Z","timestamp":1487692574000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Buprenorphine for managing opioid withdrawal"],"prefix":"10.1002","volume":"2017","author":[{"given":"Linda","family":"Gowing","sequence":"first","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Frome Road Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ali","sequence":"additional","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Frome Road Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M","family":"White","sequence":"additional","affiliation":[{"name":"University of South Australia; School of Pharmacy and Medical Sciences; GPO Box 2471 Adelaide Australia SA 5001"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalitso","family":"Mbewe","sequence":"additional","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Frome Road Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1300\/J069v13n03_04","article-title":"A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification","volume":"13","author":"Amass","year":"1994","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsat.2004.05.002","article-title":"Opioid detoxification using high doses of buprenorphine in 24 hours: a randomised, double-blind, controlled clinical trial","volume":"27","author":"Assadi","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0003|cit3","first-page":"182","article-title":"A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties","volume":"76","author":"Bickel","year":"1987","journal-title":"NIDA Research Monograph"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/clpt.1988.13","article-title":"A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts","volume":"43","author":"Bickel","year":"1988","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0376-8716(94)90093-0","article-title":"A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids","volume":"36","author":"Cheskin","year":"1994","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1002\/14651858.CD002025.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jama.294.8.903","article-title":"Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction. A randomised trial","volume":"294","author":"Collins","year":"2005","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1002\/14651858.CD002025.pub5-BIB0007|cit7","first-page":"S35","article-title":"A randomised comparison of anaesthesia-assisted heroin detoxification with buprenorphine- and clonidine-assisted detoxifications","volume":"66","author":"Collins","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5055\/jom.2005.0009","article-title":"A randomized trial of one-day vs. three-day buprenorphine inpatient detoxification protocols for heroin dependence","volume":"1","author":"Hopper","year":"2005","journal-title":"Journal of Opioid Management"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0009|cit9","first-page":"FC01","article-title":"Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal: a hospital based study","volume":"9","author":"Hussain","year":"2015","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0376-8716(94)90096-5","article-title":"Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine","volume":"36","author":"Janiri","year":"1994","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0167-0115(94)90351-4","article-title":"Low-dose buprenorphine detoxification in long term methadone addicts","volume":"Suppl","author":"Janiri","year":"1994","journal-title":"Regulatory Peptides"},{"issue":"Suppl","key":"10.1002\/14651858.CD002025.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1080\/10550490490440807","article-title":"Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network Field Experience","volume":"13","author":"Amass","year":"2004","journal-title":"American Journal on Addictions"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/10550880903438925","article-title":"Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes","volume":"29","author":"Hillhouse","year":"2010","journal-title":"Journal of Addictive Diseases"},{"issue":"8","key":"10.1002\/14651858.CD002025.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2005.01154.x","article-title":"A multi-centre randomised trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network","volume":"100","author":"Ling","year":"2005","journal-title":"Addiction"},{"issue":"1-3","key":"10.1002\/14651858.CD002025.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2008.06.016","article-title":"Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence","volume":"99","author":"Ziedonis","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/15332641003772587","article-title":"Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy","volume":"9","author":"Brown","year":"2010","journal-title":"Journal of Ethnicity in Substance Abuse"},{"issue":"5","key":"10.1002\/14651858.CD002025.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/00952990.2011.596974","article-title":"Participant characteristics and buprenorphine dose","volume":"37","author":"Hillhouse","year":"2011","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jsat.2012.08.016","article-title":"Predictors of outcome after short-term stabilization with buprenorphine","volume":"44","author":"Hillhouse","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1360-0443.2008.02455.x","article-title":"Buprenorphine tapering schedule and illicit opioid use","volume":"104","author":"Ling","year":"2009","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/ADM.0b013e318277e92e","article-title":"A comparison of buprenorphine taper outcomes between prescription opioid and heroin users","volume":"7","author":"Nielsen","year":"2013","journal-title":"Journal of Addiction Medicine"},{"issue":"7","key":"10.1002\/14651858.CD002025.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0034-1390467","article-title":"Modeling longitudinal changes in buprenorphine treatment outcome for opioid dependence","volume":"47","author":"Saleh","year":"2014","journal-title":"Pharmacopsychiatry"},{"issue":"24","key":"10.1002\/14651858.CD002025.pub5-BIB0022|cit22","first-page":"3935","article-title":"Predictors of long term opioid withdrawal outcome after short-term stabilization with buprenorphine","volume":"18","author":"Saleh","year":"2014","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"11","key":"10.1002\/14651858.CD002025.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1360-0443.2002.00215.x","article-title":"A randomised controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal","volume":"97","author":"Lintzeris","year":"2002","journal-title":"Addiction"},{"issue":"10","key":"10.1002\/14651858.CD002025.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","article-title":"Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial","volume":"62","author":"Marsch","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/ADM.0b013e3182191099","article-title":"Improvement in psychopathology among opioid-dependent adolescents during behavioral-pharmacological treatment","volume":"5","author":"Moore","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/ADM.0b013e31816b2f84","article-title":"Differences in treatment outcomes between prescription opioid-dependent and heroin-dependent adolescents","volume":"2","author":"Motamed","year":"2008","journal-title":"Journal of Addiction Medicine"},{"issue":"8","key":"10.1002\/14651858.CD002025.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/add.13363","article-title":"A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults","volume":"111","author":"Marsch","year":"2016","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0740-5472(93)90024-V","article-title":"Buprenorphine in opiate withdrawal: a comparison with clonidine","volume":"10","author":"Nigam","year":"1993","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1002\/14651858.CD002025.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-127-7-199710010-00004","article-title":"Three methods of opioid detoxification in a primary care setting. A randomized trial","volume":"127","author":"O'Connor","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0030|cit30","first-page":"309","article-title":"Three methods of ambulatory opiate detoxification: preliminary results of a randomised clinical trial","volume":"132","author":"Shi","year":"1993","journal-title":"NIDA Research Monograph"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2004.07.008","article-title":"A double-blind, double-dummy, randomized, prospective pilot study of the partial Mu opiate agonist, buprenorphine, for acute detoxification from heroin","volume":"77","author":"Oreskovich","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl","key":"10.1002\/14651858.CD002025.pub5-BIB0032|cit32","first-page":"S138","article-title":"Buprenorphine versus methadone in opiate detoxification: preliminary results","volume":"66","author":"Petitjean","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1002\/14651858.CD002025.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.addbeh.2006.01.014","article-title":"Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine","volume":"31","author":"Ponizovsky","year":"2006","journal-title":"Addictive Behaviors"},{"issue":"12","key":"10.1002\/14651858.CD002025.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/j.1360-0443.2005.01273.x","article-title":"A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial","volume":"100","author":"Raistrick","year":"2005","journal-title":"Addiction"},{"issue":"9","key":"10.1002\/14651858.CD002025.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s001150050656","article-title":"Detoxification of poly-substance abusers with buprenorphine. Effects on affect, anxiety, and withdrawal symptoms","volume":"71","author":"Paetzold","year":"2000","journal-title":"Nervenarzt"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/13556210071289","article-title":"Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study","volume":"5","author":"Schneider","year":"2000","journal-title":"Addiction Biology"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/13556210500123191","article-title":"Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone","volume":"10","author":"Seifert","year":"2005","journal-title":"Addiction Biology"},{"issue":"5","key":"10.1002\/14651858.CD002025.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2002-34115","article-title":"Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone","volume":"35","author":"Seifert","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.02.033","article-title":"Characterizing opioid withdrawal during double-blind buprenorphine detoxification","volume":"151","author":"Dunn","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1002\/14651858.CD002025.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.addbeh.2014.04.023","article-title":"Spontaneous reductions in smoking during double-blind buprenorphine detoxification","volume":"39","author":"Patrick","year":"2014","journal-title":"Addictive Behaviors"},{"issue":"12","key":"10.1002\/14651858.CD002025.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamapsychiatry.2013.2216","article-title":"A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers","volume":"70","author":"Sigmon","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1055\/s-2006-940205","article-title":"Should methadone or buprenorphine be preferred for opiate detoxification?","volume":"34","author":"Steinmann","year":"2007","journal-title":"Psychiatrische Praxis"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1024\/2008.04.03","article-title":"Methadone versus buprenorphine for inpatient detoxification treatment","volume":"54","author":"Steinmann","year":"2008","journal-title":"Sucht"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0376-8716(02)00325-3","article-title":"Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection","volume":"69","author":"Umbricht","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0045|cit45","first-page":"114","article-title":"Double-blind controlled detoxification from buprenorphine","volume":"162","author":"Wang","year":"1996","journal-title":"NIDA Research Monograph"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1745-6215-10-53","article-title":"The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification","volume":"10","author":"Sheard","year":"2009","journal-title":"Trials"},{"issue":"593","key":"10.1002\/14651858.CD002025.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.3399\/bjgp11X613106","article-title":"Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial","volume":"61","author":"Wright","year":"2011","journal-title":"British Journal of General Practice"},{"issue":"1-2","key":"10.1002\/14651858.CD002025.pub5-BIB0048|cit48","first-page":"18","article-title":"A comparison of the efficacy of buprenorphine and clonidine in detoxification of heroin-dependents and the following maintenance treatment","volume":"2","author":"Ziaaddini","year":"2010","journal-title":"Addiction and Health"},{"issue":"3-4","key":"10.1002\/14651858.CD002025.pub5-BIB0049|cit49","first-page":"79","article-title":"Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid-dependents","volume":"4","author":"Ziaaddini","year":"2012","journal-title":"Addiction and Health"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/ADM.0b013e31816859a4","article-title":"A randomized trial of extended buprenorphine detoxification for opioid dependency","volume":"2","author":"Blondell","year":"2008","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-8716(03)00071-1","article-title":"Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions","volume":"71","author":"Breen","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1002\/14651858.CD002025.pub5-BIB0052|cit52","first-page":"e277","article-title":"Primary care buprenorphine detoxification vs. maintenance for prescription opioid dependence","volume":"146","author":"Fiellin","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1002\/14651858.CD002025.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/08897070109511459","article-title":"A comparison of clonidine and buprenorphine in the outpatient treatment of opiate withdrawal","volume":"22","author":"Fingerhood","year":"2001","journal-title":"Substance Abuse"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002025.pub5-BIB0055|cit55","first-page":"S50","article-title":"Rapid opioid detoxification using buprenorphine and naltrexone","volume":"63","author":"Frownfelter","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1360-0443.2003.00334.x","article-title":"Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users","volume":"98","author":"Gandhi","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/095952304100017044154","article-title":"A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal","volume":"23","author":"Doran","year":"2004","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5694\/j.1326-5377.2003.tb05417.x","article-title":"A comparison of buprenorphine treatment in clinic and primary care settings: A randomised trial","volume":"179","author":"Gibson","year":"2003","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/j.drugalcdep.2014.09.256","article-title":"Memantine improves buprenorphine treatment for opioid-dependent young adults","volume":"146","author":"Gonzalez","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.drugalcdep.2015.09.020","article-title":"Memantine improves buprenorphine treatment for opioid-dependent young adults","volume":"156","author":"Gonzalez","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/02791072.2000.10400450","article-title":"A comparative clinical study of the effect of WeiniCom, a Chinese herbal compound, on alleviation of withdrawal symptoms and craving for heroin in detoxification treatment","volume":"32","author":"Hao","year":"2000","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0062|cit62","first-page":"243","article-title":"A comparison of buprenorphine with lofexidine in the rapid opiate detoxification of patients with opiate dependency receiving treatment in a community setting","volume":"8","author":"Harris","year":"2003","journal-title":"Addiction Biology"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0063|cit63","first-page":"10","article-title":"A comparative study of buprenorphine plus naloxone vs opium tincture in the detoxification treatment of heroin dependence","volume":"4","author":"He","year":"1999","journal-title":"Chinese Journal of Clinical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5055\/jom.2011.0044","article-title":"A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts","volume":"7","author":"Jain","year":"2011","journal-title":"Journal of Opioid Management"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0065|cit65","first-page":"60","article-title":"Effect of methadone plus buprenorphine on the alleviation of heroin withdrawal symptoms","volume":"9","author":"Jia","year":"2001","journal-title":"Chinese Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0066|cit66","first-page":"384","article-title":"Outpatient maintenance\/detoxification comparison of methadone and buprenorphine","volume":"95","author":"Johnson","year":"1989","journal-title":"NIDA Research Monograph"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0067|cit67","first-page":"167","article-title":"A comparison of buprenorphine to clonidine for rapid inpatient opiate detoxification","volume":"51","author":"Johnson","year":"1992","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"20","key":"10.1002\/14651858.CD002025.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0069|cit69","first-page":"200","article-title":"Comparison of the withdrawal syndromes following abrupt termination of buprenorphine and methadone","volume":"162","author":"Johnson","year":"1996","journal-title":"NIDA Research Monograph"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/00952990802585380","article-title":"Brief vs extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes","volume":"35","author":"Katz","year":"2009","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"6","key":"10.1002\/14651858.CD002025.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0024-3205(88)90454-7","article-title":"Buprenorphine detoxification from opioid dependence: a pilot study","volume":"42","author":"Kosten","year":"1988","journal-title":"Life Sciences"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0376-8716(90)90144-4","article-title":"Opioid antagonist challenges in buprenorphine maintained patients","volume":"25","author":"Kosten","year":"1990","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1002\/14651858.CD002025.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1176\/ajp.146.10.1349a","article-title":"Rapid detoxification from opioid dependence","volume":"146","author":"Kosten","year":"1989","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0074|cit74","first-page":"101","article-title":"Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone","volume":"121","author":"Kosten","year":"1992","journal-title":"NIDA Research Monograph"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00952999108992815","article-title":"Treatment of heroin addicts using buprenorphine","volume":"17","author":"Kosten","year":"1991","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002025.pub5-BIB0076|cit76","first-page":"S100","article-title":"BD RCT of Suboxone (buprenorphine\/naloxone) vs. methadone\/lofexidine for stabilization and withdrawal of low-dose outpatient opiate addicts","volume":"66","author":"Law","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002025.pub5-BIB0077|cit77","first-page":"S156","article-title":"A double-blind randomised controlled trial of buprenorphine\/naloxone (suboxone) versus methadone\/lofexidine for the detoxification of opiate-dependent addicts","volume":"60","author":"Myles","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0078|cit78","first-page":"S114","article-title":"Buprenorphine initiation and linkage to outpatient buprenorphine treatment does not reduce frequency of injection drug use for inpatient opioid-dependent injection drug users: results of a randomized clinical trial","volume":"30","author":"Cushman","year":"2015","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0079|cit79","first-page":"S108","article-title":"Initiating buprenorphine maintenance for opiate-dependent hospitalized patients: a randomized controlled trial","volume":"28","author":"Liebschutz","year":"2013","journal-title":"Journal of General Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD002025.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0376-8716(03)00015-2","article-title":"Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration study","volume":"70","author":"Lintzeris","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0082|cit82","first-page":"112","article-title":"Rapid detoxification of heroin dependence by buprenorphine","volume":"18","author":"Liu","year":"1997","journal-title":"Acta Pharmacologica Sinica"},{"issue":"6","key":"10.1002\/14651858.CD002025.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.euroneuro.2007.12.003","article-title":"The effect of DHEA complementary treatment on heroin addicts participating in a rehabilitation program: a preliminary study","volume":"18","author":"Maayan","year":"2008","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jsat.2009.05.010","article-title":"A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification","volume":"38","author":"Meade","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0085|cit85","first-page":"131","article-title":"Inpatient medically supervised opioid withdrawal, with buprenorphine alone and in combination with naltrexone","volume":"55","author":"Montoya","year":"1994","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/JCP.0b013e31823f91d1","article-title":"Actigraphic measurements in opioid detoxification with methadone or buprenorphine","volume":"32","author":"Pjrek","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0087|cit87","first-page":"453","article-title":"Buprenorphine: rapid and slow dose-reductions for heroin detoxification","volume":"141","author":"Pycha","year":"1994","journal-title":"NIDA Research Monograph"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/JCP.0b013e318032ec2a","article-title":"Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?","volume":"27","author":"Reed","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0089|cit89","first-page":"109","article-title":"Buprenorphine: an alternative to methadone for heroin dependence treatment","volume":"28","author":"Resnick","year":"1992","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0090|cit90","article-title":"Detoxification and induction onto naltrexone","volume-title":"Buprenorphine: Combatting Drug Abuse with a Unique Opioid","author":"Rosen","year":"1995"},{"issue":"12","key":"10.1002\/14651858.CD002025.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/add.12315","article-title":"Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine\/naloxone","volume":"108","author":"Rosenthal","year":"2013","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1037\/a0033724","article-title":"Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure","volume":"21","author":"Sanders","year":"2013","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-8-1","article-title":"The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project pilot study: protocol for a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification","volume":"8","author":"Sheard","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-597X-4-1","article-title":"The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification","volume":"4","author":"Sheard","year":"2009","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"11","key":"10.1002\/14651858.CD002025.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1360-0443.2004.00834.x","article-title":"Evaluation of an injection depot formulation of buprenorphine: placebo comparison","volume":"99","author":"Sigmon","year":"2004","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1016\/j.drugalcdep.2014.09.671","article-title":"Long-acting injectable naltrexone induction: a randomized trial of outpatient opioid detoxification with naltrexone vs buprenorphine","volume":"146","author":"Sullivan","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/jpet.113.209478","article-title":"A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine","volume":"348","author":"Tompkins","year":"2014","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(99)00033-2","article-title":"Naltrexone shortened opioid detoxification with buprenorphine","volume":"56","author":"Umbricht","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1002\/14651858.CD002025.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cct.2010.01.003","article-title":"A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology","volume":"31","author":"Weiss","year":"2010","journal-title":"Contemporary Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(01)00149-1","article-title":"Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine","volume":"65","author":"White","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1017\/S0790966700007114","article-title":"Buprenorphine detoxification treatment for heroin dependence: a preliminary experience in an outpatient setting","volume":"19","author":"Williams","year":"2002","journal-title":"Irish Journal of Psychological Medicine"},{"issue":"1-2","key":"10.1002\/14651858.CD002025.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.drugalcdep.2013.02.030","article-title":"Association of cannabis use with opioid outcomes among opioid-dependent youth","volume":"132","author":"Hill","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAI.0b013e3181d916db","article-title":"HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study","volume":"55","author":"Meade","year":"2010","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"9","key":"10.1002\/14651858.CD002025.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1360-0443.2010.03001.x","article-title":"Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial","volume":"105","author":"Polsky","year":"2010","journal-title":"Addiction"},{"issue":"11","key":"10.1002\/14651858.CD002025.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jaac.2011.07.010","article-title":"Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine\/naloxone treatment trial in opioid-dependent youth","volume":"50","author":"Subramaniam","year":"2011","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD002025.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addbeh.2012.04.011","article-title":"Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth","volume":"37","author":"Warden","year":"2012","journal-title":"Addictive Behaviors"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00952990.2011.600393","article-title":"Compensation effects on clinical trial data collection in opioid-dependent young adults","volume":"38","author":"Wilcox","year":"2012","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"17","key":"10.1002\/14651858.CD002025.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2296-5-9","article-title":"The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728]","volume":"5","author":"Oldham","year":"2004","journal-title":"BMC Family Practice"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2296-8-3","article-title":"Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial","volume":"8","author":"Wright","year":"2007","journal-title":"BMC Family Practice"},{"issue":"5","key":"10.1002\/14651858.CD002025.pub5-BIB0112|cit112","first-page":"295","article-title":"Comparative study of buprenorphine and methadone in the treatment of heroin addicts","volume":"19","author":"Zhang","year":"1993","journal-title":"Chinese Journal of Neurological and Mental Diseases"},{"issue":"9","key":"10.1002\/14651858.CD002025.pub5-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005031.pub2","article-title":"Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003409.pub4","article-title":"Methadone at tapered doses for the management of opioid withdrawal","author":"Amato","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02791072.2006.10400589","article-title":"Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients","volume":"38","author":"Ang-Lee","year":"2006","journal-title":"Journal of Psychoactive Drugs"},{"issue":"7454","key":"10.1002\/14651858.CD002025.pub5-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0740-5472(94)90059-0","article-title":"An open trial of low dose buprenorphine in treating methadone withdrawal","volume":"11","author":"Banys","year":"1994","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(99)00063-0","article-title":"Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months","volume":"58","author":"Broers","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/146598901300271103","article-title":"A pilot study of the effectiveness of buprenorphine and methadone as detoxication agents when choice is given to the consumer","volume":"6","author":"Cameron","year":"2001","journal-title":"Journal of Substance Use"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jsat.2005.08.011","article-title":"Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy and symptoms","volume":"29","author":"Chawarski","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Suppl","key":"10.1002\/14651858.CD002025.pub5-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0376-8716(03)00058-9","article-title":"Pharmacokinetics of the combination tablet of buprenorphine and naloxone","volume":"70","author":"Chiang","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004580.pub2","article-title":"Inpatient versus other settings for detoxification for opioid dependence","author":"Day","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD002025.pub5-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clinical Pharmacokinetics"},{"issue":"11","key":"10.1002\/14651858.CD002025.pub5-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1360-0443.1994.tb03745.x","article-title":"Opiate withdrawal","volume":"89","author":"Farrell","year":"1994","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0376-8716(88)90078-6","article-title":"Clonidine and the treatment of the opiate withdrawal syndrome","volume":"21","author":"Gossop","year":"1988","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1192\/bjp.154.3.348","article-title":"Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study","volume":"154","author":"Gossop","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1192\/bjp.154.3.360","article-title":"Opiate withdrawal symptoms in response to 10 day and 21 day methadone withdrawal programmes","volume":"154","author":"Gossop","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0128|cit128","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002021.pub3","article-title":"Opioid antagonists with minimal sedation for the management of opioid withdrawal","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002022.pub3","article-title":"Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal","author":"Gowing","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0130|cit130","unstructured":"Gowing L Ali R Dunlop A Farrell M Lintzeris N National Guidelines for Medication-Assisted Treatment of Opioid Dependence. Commonwealth of Australia, 2014 www.nationaldrugstrategy.gov.au\/internet\/drugstrategy\/Publishing.nsf\/content\/ng-mat-op-dep"},{"issue":"6","key":"10.1002\/14651858.CD002025.pub5-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/add.12899","article-title":"Global statistics on addictive behaviours: 2014 status report","volume":"110","author":"Gowing","year":"2015","journal-title":"Addiction"},{"issue":"5","key":"10.1002\/14651858.CD002025.pub5-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002024.pub5","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0133|cit133","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT 2014"},{"issue":"7560","key":"10.1002\/14651858.CD002025.pub5-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7651","key":"10.1002\/14651858.CD002025.pub5-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"Rating quality of evidence and strength of recommendations: What is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0137|cit137","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0138|cit138","article-title":"Opiates: Clinical Aspects","volume-title":"Substance Abuse: A Comprehensive Textbook","author":"Jaffe","year":"1997"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD002025.pub5-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: how to use it right","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD002025.pub5-BIB0140|cit140","first-page":"30","article-title":"The treatment of narcotic withdrawal: a historical review","volume":"43","author":"Kleber","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0141|cit141","first-page":"113","article-title":"Heroin detoxification with a single high dose of buprenorphine","volume":"39","author":"Kutz","year":"2002","journal-title":"Israel Journal of Psychiatry and Related Sciences"},{"issue":"10","key":"10.1002\/14651858.CD002025.pub5-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1360-0443.2007.01944.x","article-title":"Evaluation of a transdermal buprenorphine formulation in opioid detoxification","volume":"102","author":"Lanier","year":"2007","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00213-008-1105-z","article-title":"Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation","volume":"198","author":"Lanier","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"issue":"2-3","key":"10.1002\/14651858.CD002025.pub5-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2011.04.002","article-title":"Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing","volume":"118","author":"Larance","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"1-2","key":"10.1002\/14651858.CD002025.pub5-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drugalcdep.2012.12.009","article-title":"A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence","volume":"131","author":"Lintzeris","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1300\/J251v02n01_03","article-title":"Detoxification from heroin dependency: an overview of method and effectiveness","volume":"2","author":"Lipton","year":"1983","journal-title":"Advances in Alcohol and Substance Abuse"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"8994","key":"10.1002\/14651858.CD002025.pub5-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(96)90215-9","article-title":"Are detoxification programmes effective?","volume":"347","author":"Mattick","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0149|cit149","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0150|cit150","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006749.pub3","article-title":"Detoxification treatments for opiate dependent adolescents","author":"Minozzi","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.149.2.235","article-title":"The influence of psychological factors on the opiate withdrawal syndrome","volume":"149","author":"Phillips","year":"1986","journal-title":"British Journal of Psychiatry"},{"issue":"6-7","key":"10.1002\/14651858.CD002025.pub5-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/10826088509047756","article-title":"Pharmacological advances in addiction treatment","volume":"20","author":"Preston","year":"1985","journal-title":"International Journal of the Addictions"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0153|cit153","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"5","key":"10.1002\/14651858.CD002025.pub5-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/ajp.150.5.695","article-title":"Should protracted withdrawal from drugs be included in DSM-IV?","volume":"150","author":"Satel","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002025.pub5-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2003.08.006","article-title":"Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification","volume":"73","author":"Sobel","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.008","article-title":"Relative bioavailability of different buprenorphine formulations under chronic dosing conditions","volume":"74","author":"Strain","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/105504999305956","article-title":"Heroin chasers and heroin injectors: differences observed in a community sample in London, UK","volume":"8","author":"Strang","year":"1999","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0158|cit158","first-page":"589","article-title":"Management of opioid intoxication and withdrawal","volume-title":"Principles of Addiction Medicine","author":"Tetrault","year":"2009"},{"issue":"10","key":"10.1002\/14651858.CD002025.pub5-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1360-0443.1988.tb03021.x","article-title":"What can long-term follow-up teach us about relapse and prevention of relapse in addiction?","volume":"83","author":"Vaillant","year":"1988","journal-title":"British Journal of Addiction"},{"key":"10.1002\/14651858.CD002025.pub5-BIB0160|cit160","volume-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"World Health Organization","year":"2009"},{"issue":"4","key":"10.1002\/14651858.CD002025.pub5-BIB0161|cit161","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002025.pub4","article-title":"Buprenorphine for the management of opioid withdrawal","author":"Gowing","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD002025.pub5-BIB0162|cit162","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002025.pub4","article-title":"Buprenorphine for the management of opioid withdrawal","author":"Gowing","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD002025.pub5-BIB0163|cit163","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002025.pub4","article-title":"Buprenorphine for the management of opioid withdrawal","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002025.pub5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T04:04:09Z","timestamp":1681445049000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002025.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":163,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002025.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}